There was also a statistically significant reduction in the risk of breast cancer in BRCA1 mutation carriers based on the variable comparing of starting intake of OC at the age below vs. above 20 years; OR = 0.78, p = 0.0002 (Table 2). Here, BRCA1 is linked to breast cancer.